Oberreiter, K.; Moser, M.M.; Schneider, L.; Burgmann, H.; Moreal, C.; Giuliano, S.; Angelini, J.; Tascini, C.; Vossen, M.G.
Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers. Antibiotics 2026, 15, 421.
https://doi.org/10.3390/antibiotics15040421
AMA Style
Oberreiter K, Moser MM, Schneider L, Burgmann H, Moreal C, Giuliano S, Angelini J, Tascini C, Vossen MG.
Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers. Antibiotics. 2026; 15(4):421.
https://doi.org/10.3390/antibiotics15040421
Chicago/Turabian Style
Oberreiter, Karin, Miriam M. Moser, Lisa Schneider, Heinz Burgmann, Chiara Moreal, Simone Giuliano, Jacopo Angelini, Carlo Tascini, and Matthias G. Vossen.
2026. "Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers" Antibiotics 15, no. 4: 421.
https://doi.org/10.3390/antibiotics15040421
APA Style
Oberreiter, K., Moser, M. M., Schneider, L., Burgmann, H., Moreal, C., Giuliano, S., Angelini, J., Tascini, C., & Vossen, M. G.
(2026). Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers. Antibiotics, 15(4), 421.
https://doi.org/10.3390/antibiotics15040421
